CN103055219B - A kind of respiratory diseases in pigs health care Chinese medicine powder and preparation technology thereof - Google Patents
A kind of respiratory diseases in pigs health care Chinese medicine powder and preparation technology thereof Download PDFInfo
- Publication number
- CN103055219B CN103055219B CN201210542262.1A CN201210542262A CN103055219B CN 103055219 B CN103055219 B CN 103055219B CN 201210542262 A CN201210542262 A CN 201210542262A CN 103055219 B CN103055219 B CN 103055219B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- health care
- stemona
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 37
- 208000023504 respiratory system disease Diseases 0.000 title claims abstract description 20
- 239000000843 powder Substances 0.000 title claims abstract description 17
- 241000282887 Suidae Species 0.000 title claims abstract description 16
- 230000036541 health Effects 0.000 title claims abstract description 16
- 238000005516 engineering process Methods 0.000 title claims abstract description 10
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 241001671204 Stemona Species 0.000 claims abstract description 19
- 239000000463 material Substances 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims abstract 2
- 241000220259 Raphanus Species 0.000 claims 2
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims 2
- 229940126678 chinese medicines Drugs 0.000 claims 1
- 210000000582 semen Anatomy 0.000 abstract description 17
- 239000002075 main ingredient Substances 0.000 abstract description 11
- 241000282898 Sus scrofa Species 0.000 description 31
- 238000012360 testing method Methods 0.000 description 29
- 208000030303 breathing problems Diseases 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 208000011580 syndromic disease Diseases 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 9
- 230000000241 respiratory effect Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 230000037396 body weight Effects 0.000 description 6
- 235000014590 basal diet Nutrition 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 235000019786 weight gain Nutrition 0.000 description 5
- 208000003322 Coinfection Diseases 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 239000003390 Chinese drug Substances 0.000 description 3
- 241000725681 Swine influenza virus Species 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 102100038353 Gremlin-2 Human genes 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 101001032860 Mus musculus Gremlin-2 Proteins 0.000 description 2
- 241000204031 Mycoplasma Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- PQCLJXVUAWLNSV-UHFFFAOYSA-N 5-Methyl-2,3-hexanedione Chemical group CC(C)CC(=O)C(C)=O PQCLJXVUAWLNSV-UHFFFAOYSA-N 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000004182 Tylosin Substances 0.000 description 1
- 229930194936 Tylosin Natural products 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 235000021053 average weight gain Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- LXWYCLOUQZZDBD-LIYNQYRNSA-N csfv Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C1=CC=C(O)C=C1 LXWYCLOUQZZDBD-LIYNQYRNSA-N 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 206010015915 eye discharge Diseases 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000012153 swine disease Diseases 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 description 1
- 229960004059 tylosin Drugs 0.000 description 1
- 235000019375 tylosin Nutrition 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention provides a kind of respiratory diseases in pigs health care Chinese medicine powder, it is characterized in that being combined by weight proportion by following main ingredient, 20-35 parts of Bulbus Fritillariae Cirrhosaes, 20-35 parts of the tubers of stemona, 15-25 parts, Radix Glycyrrhizae, 20-35 parts of radix platycodis, 10-20 parts of SEMEN RAPHANIs. The present invention also provides the preparation technology of this Chinese prescription, it is characterized in that preparation method's step is as follows: it is above as standby material that (1) is crushed to 180 orders with micronizer respectively using Bulbus Fritillariae Cirrhosae, the tuber of stemona, Radix Glycyrrhizae, four kinds of main ingredients of radix platycodi. (2) SEMEN RAPHANI is crushed to 40 orders with pulverizer above for subsequent use. (3) take above-mentioned for subsequent use former medicine by above-mentioned part by weight respectively and be placed in V-Mixer and mix 25-30 minutes, blanking is packaged into bag.
Description
Technical field
The invention belongs to herbal medicine field of pharmaceutical technology, for a kind of traditional Chinese powder medicine and preparation technology of respiratory diseases in pigs health care.
Background technology
PRDC is a kind of disease of complexity, worldwide endangers pig industry. PRDC sees the pig farm of different management and facility; comprise large scale of pig farm field; it is the breathing problem of a kind of normal occurring in pig industry in recent years; it is the mixed infection by some pathogen, and the comprehensive disease causing in the acting in conjunction of the many factors such as environmental condition, feeding and management. The sick syndrome of porcine respiratory has become the most important thing of the current swine disease of China, almost there is generation on all pig farms, and be difficult to remove, it is except causing direct death, more seriously slowly (5%--25%), efficiency of feed utilization reduce (5%--25%), marketing time is postponed (15--20 days) to make pig weightening finish, and carry for a long time multiple related diseases substance. The incidence of disease on some pig farm can reach 40%--80%, immediate mortality more than 10%, weightening finish decline or growth retardation reach 70%, some pig farms are even forced to the pig in this stage all to eliminate, and have a strong impact on the economic benefit on pig farm.
At present, the popular feature that has occurred that some are new of breathing problem syndrome, the one, the pathogen of mixed infection changes more to some extent, shows as by one or more bacteriums, virus the mixed infection causing. There are in the porcine respiratory of breathing problem syndrome clinical symptoms three kinds of cause of diseases that are the most often separated to: mycoplasma pneumoniae (MH), porcine reproductive and respiratory syndrome virus (PRRSV) and swine influenza virus (SIV). The 2nd, the change of disease time, after wean, the pig in each stage all can fall ill, and 2 weeks from weaning start, until breathing problem syndrome can occur fattening period, each stage of sow also can hair tonic respiratory syndrome. The 3rd, the mixed infections such as the normal and bacterium of this virus, mycoplasma, PCV-II, CSFV, Pseudorabies virus, swine influenza virus, PRCV, make the incidence of disease such as swinery bacteriosis, swine fever, pseudoabies increase, other diseases as eperythrozoon, streptococcosis, wean after multisystem exhaustion syndrome also increase. Therefore, porcine respiratory disease has become the obstacle of large-scale pig farm maximum. The health hygienic work of carrying out pig farm breathing problem is very important.
The medicine that is used for the treatment of at present such disease is a lot, but mainly taking chemical classes medicine as main, due to long-term clinical Irrational Use of Drugs, causes drug resistance to strengthen year by year, and its curative effect also reduces gradually. Therefore, adopt herbal medicine preparation to treat porcine respiratory disease syndrome and become goal in research in recent years.
Summary of the invention
The object that technical problem to be solved by this invention invents is: the traditional Chinese powder medicine for respiratory diseases in pigs health care of a kind of good effect, good stability is provided, and the health care that both can be used for respiratory diseases in pigs also can be used for the treatment of clinical breathing problem.
The technical scheme that realizes the object of the invention and adopt is:
A kind of respiratory diseases in pigs health care Chinese medicine powder, is characterized in that being combined by weight proportion by following main ingredient: Bulbus Fritillariae Cirrhosae 20---35 parts, the tuber of stemona 20---35 parts, Radix Glycyrrhizae 15---20 parts of 25 parts, radix platycodis 20---35 parts, SEMEN RAPHANI 10---.
The preparation technology of above-mentioned said Chinese prescription, is characterized in that preparation method's step is as follows:
(1) Bulbus Fritillariae Cirrhosae, the tuber of stemona, Radix Glycyrrhizae, four kinds of main ingredients of radix platycodi are crushed to 180 orders with micronizer respectively above as standby material;
(2) SEMEN RAPHANI is crushed to 40 orders with pulverizer above for subsequent use;
(3) taking above-mentioned for subsequent use former medicine by above-mentioned part by weight is respectively placed in V-Mixer and mixes 25---30 minutes, to obtain final product.
The using method of above-mentioned said a kind of respiratory diseases in pigs health care Chinese medicine powder is: spice is fed, and every 1000 kilogram of feed are admixed 3 kilograms of this product, evenly mixes pig free choice feeding.
The usefulness of technique scheme is:
1, a kind of respiratory diseases in pigs health care Chinese medicine powder of the present invention and preparation technology, the advantage possessing through test confirmation and positive effect show as, clinical testing is used this powder can prevent the generation of pig farm breathing problem, and to having infected the live pig of breathing problem, its cure rate can reach more than 80%, and the generation that has no drug resistance. Clinical testing evaluation thinks, Bulbus Fritillariae Cirrhosae has moistening lung only to cough and reduce phlegm, the effect of heat-clearing dissipating bind; Antibacterial and the anti-viral effect of tuber of stemona tool antibechic; Radix Glycyrrhizae has the effects such as clearing heat and detoxicating cough-relieving; Radix platycodi has antibechic, antipyretic and antiinflammatory action; SEMEN RAPHANI has the effect of anti-inflammatory, analgesia and removing toxic substances. This traditional Chinese medicine of the five flavours itself has and complements each other, and is the effective combination that prevents and treats breathing problem, and the powder patent medicine being prepared into through technique of the present invention has good clinical effectiveness.
2, this research prescription employing Bulbus Fritillariae Cirrhosae, the tuber of stemona, Radix Glycyrrhizae, radix platycodi, SEMEN RAPHANI are main ingredient, and wherein Bulbus Fritillariae Cirrhosae has moistening lung only to cough and reduce phlegm, the effect of heat-clearing dissipating bind; Antibacterial and the anti-viral effect of tuber of stemona tool antibechic; Radix Glycyrrhizae has the effects such as clearing heat and detoxicating cough-relieving; Radix platycodi has antibechic, antipyretic and antiinflammatory action; SEMEN RAPHANI has the effect of anti-inflammatory, analgesia and removing toxic substances. Be aided with the health care that suitable powder pharmaceutical technology can be used for porcine respiratory, its clinical effectiveness is good.
Detailed description of the invention
Make specific description below in conjunction with the embodiment providing.
Embodiment 1:
(1) 20 parts of Bulbus Fritillariae Cirrhosaes, 20 parts of the tubers of stemona, 15 parts, Radix Glycyrrhizae, 25 parts of radix platycodis, 10 parts of SEMEN RAPHANIs.
(2) Bulbus Fritillariae Cirrhosae, the tuber of stemona, Radix Glycyrrhizae, four kinds of main ingredients of radix platycodi are crushed to 180 orders with micronizer respectively above as standby material; SEMEN RAPHANI is crushed to 40 orders with pulverizer above for subsequent use; Taking above-mentioned for subsequent use former medicine by above-mentioned part by weight is respectively placed in V-Mixer and mixes 25---and 30 minutes, blanking was packaged into bag.
Embodiment 2:
(1) 25 parts of Bulbus Fritillariae Cirrhosaes, 25 parts of the tubers of stemona, 18 parts, Radix Glycyrrhizae, 25 parts of radix platycodis, 12 parts of SEMEN RAPHANIs.
(2) Bulbus Fritillariae Cirrhosae, the tuber of stemona, Radix Glycyrrhizae, four kinds of main ingredients of radix platycodi are crushed to 180 orders with micronizer respectively above as standby material; SEMEN RAPHANI is crushed to 40 orders with pulverizer above for subsequent use; Taking above-mentioned for subsequent use former medicine by above-mentioned part by weight is respectively placed in V-Mixer and mixes 25---and 30 minutes, blanking was packaged into bag.
Embodiment 3:
(1) 23 parts of Bulbus Fritillariae Cirrhosaes, 28 parts of the tubers of stemona, 18 parts, Radix Glycyrrhizae, 30 parts of radix platycodis, 15 parts of SEMEN RAPHANIs.
(2) Bulbus Fritillariae Cirrhosae, the tuber of stemona, Radix Glycyrrhizae, four kinds of main ingredients of radix platycodi are crushed to 180 orders with micronizer respectively above as standby material; SEMEN RAPHANI is crushed to 40 orders with pulverizer above for subsequent use; Taking above-mentioned for subsequent use former medicine by above-mentioned part by weight is respectively placed in V-Mixer and mixes 25---and 30 minutes, blanking was packaged into bag.
Embodiment 4:
(1) 25 parts of Bulbus Fritillariae Cirrhosaes, 30 parts of the tubers of stemona, 20 parts, Radix Glycyrrhizae, 30 parts of radix platycodis, 15 parts of SEMEN RAPHANIs.
(2) Bulbus Fritillariae Cirrhosae, the tuber of stemona, Radix Glycyrrhizae, four kinds of main ingredients of radix platycodi are crushed to 180 orders with micronizer respectively above as standby material; SEMEN RAPHANI is crushed to 40 orders with pulverizer above for subsequent use; Taking above-mentioned for subsequent use former medicine by above-mentioned part by weight is respectively placed in V-Mixer and mixes 25---and 30 minutes, blanking was packaged into bag.
Embodiment 5:
(1) 25 parts of Bulbus Fritillariae Cirrhosaes, 20 parts of the tubers of stemona, 18 parts, Radix Glycyrrhizae, 30 parts of radix platycodis, 15 parts of SEMEN RAPHANIs.
(2) Bulbus Fritillariae Cirrhosae, the tuber of stemona, Radix Glycyrrhizae, four kinds of main ingredients of radix platycodi are crushed to 180 orders with micronizer respectively above as standby material; SEMEN RAPHANI is crushed to 40 orders with pulverizer above for subsequent use; Taking above-mentioned for subsequent use former medicine by above-mentioned part by weight is respectively placed in V-Mixer and mixes 25---and 30 minutes, blanking was packaged into bag.
With the traditional Chinese powder medicine of the said a kind of respiratory diseases in pigs health care of the present invention, pig is prevented and is treated the test report example of porcine respiratory disease.
(1) a kind of test of traditional Chinese powder medicine treatment porcine respiratory disease of respiratory diseases in pigs health care.
1, materials and methods
In June, 2012, there are 650 piglets on pig farm, Guangxi Bobai County, most of piglet occurs that spirit is depressed, feed intake declines or do not eat, have a running nose, cough, have difficulty in breathing, be abdominal respiration, under ear and abdomen, skin is blue, eye discharge increases, and occurs conjunctivitis symptom etc., doubtful porcine respiratory syndrome. Select the piglet on this pig farm, male and female pig all has, 60 ~ 70 ages in days, and body weight is 23.6 ~ 25.8kg, wherein 140, be divided into 7 groups, every group of 20 piglet is for examination. Test grouping and administration: 1 ~ 5 group of test group, adopt respectively embodiment 1 ~ 5 to be prepared medicine, and respectively according to the using method medication of the embodiment of the present invention 1 ~ 5. Infecting control group is to be infected but the piglet of not administration; Normal healthy controls group is the healthy piglet without catching; All the other each group is used in conjunction 7. Observation period is 15 days after administration, and weighing and body condition observation before and after every pig is tested. Index of assessment of curative effect:
(1) death rate=dead piglet/test piglet number × 100%;
(2) cure rate=piglet is cured number/test piglet number × 100%;
(3) efficient=treat effective piglet number/test piglet number × 100%;
(4) rate of body weight gain. The body weight of every pig when starting and when off-test, the weightening finish of calculating every pig, then calculates average weight gain and the standard deviation of every group of test pig according to this. Rate of body weight gain/normal healthy controls group rate of body weight gain × 100% of the relative weight gain rate=each medication group or infected group, wherein normal healthy controls group is set as 100%;
(5) data analysis and process: use SPSS15.0 software data processing, the wherein death rate, cure rate, efficient all with Ka Shi inspection, weightening finish employing t inspection, statistical results are in table 1.
2, result
Table 1 medicine of the present invention is to porcine respiratory syndrome curative effect statistics.
Test result analysis: test group 1-5 with infect control group in the death rate, cure rate, efficiently there is significant difference (P < 0.01), test group 1-5 all has significant curative effect to porcine respiratory syndrome; Test group 1-5 has significant difference (P < 0.01) with the relative weight gain rate that infects control group, but all lower than normal healthy controls group, wherein the curative effect of test group 5 is best, judges that this group medicine is best of breed.
(2) a kind of test of traditional Chinese powder medicine prevention porcine respiratory disease of respiratory diseases in pigs health care.
1, materials and methods
1.1, test drug: above-mentioned example 5 drug regimen powders are provided by the inventor. Ai Lixin is provided by Hunan vast animal and veterinary research and development Co., Ltd, and Main Ingredients and Appearance is 5% tartaric acid acetylisovaleryl tylosin, and product authentication code is 180352242, and product batch number is 2012082401.
1.2, experimental animal: random choose kind is identical, body weight is close, raising is consistent with management condition, 90 of the piglets of approximately 80 ages in days, is divided at random 3 groups, 30 every group.
1.3, the feeding and management condition of test pig: testing each group of pig and all raise in same seat pigsty, feeds in point 6 hurdles, and every 15 pigs are closed a hurdle, free choice feeding. The basal diet of 3 groups of pigs is identical, searches for food, drinking-water, sanitary condition is consistent, adopts conventional child care phase feed diet formula to feed.
1.4, test method:
1.4.1, by 90 random packet subfields of test pig, under the same terms, feed one week, weigh on an empty stomach morning, and keep a record.
First group: in basal diet, add above-mentioned test group 5 medicine 3 kg/ton feeds, raise continuously 15, hereinafter referred to as Chinese drug-treated group.
Second group: in basal diet, add and like the new 1 kg/ton feed of profit, raise continuously 15, hereinafter referred to as Ai Lixin group.
The 3rd group: in basal diet, not adding any medicine, is control group.
After above medicine mixes with basal diet, take cafeteria feeding mode, every mornings 9 point, 4 observations in afternoon, record that piglet breathes, status of cough and death toll, until 140 ages in days.
1.4.2, the criterion of test pig breathing problem:
Slight: piglet has sneezes or coughs with interior for obvious and continuous 5 times;
Moderate: piglet has obvious and continuous 5 above coughs;
Serious: piglet has obviously and coughs and pant continuously, is abdominal respiration, and it is serious to become thin.
2, result
The situation of duration of test viewing test pig, the result of the test of record is as table 2
Table 2 test group, a situation arises for control group porcine respiratory disease.
| Respiratory symptom | Chinese drug-treated group | Ai Lixin group | Control group |
| Nothing | 27 | 26 | 16 |
| Slightly | 1 | 1 | 6 |
| Moderate | 1 | 1 | 4 |
| Seriously | 1 | 0 | 4 |
| Breathing problem incidence of disease % | 10% | 6.6% | 46.7% |
By observing, overall mental status, the diet situation of Chinese drug-treated group and Ai Lixin group test pig are better than control group, and the incidence of disease of breathing problem is also starkly lower than control group.
Claims (2)
1. a respiratory diseases in pigs health care Chinese medicine powder, is characterized in that: it is combined by weight proportion by following Chinese medicine: 20-35 parts of Bulbus Fritillariae Cirrhosaes, 20-35 parts of the tubers of stemona, 15-25 parts, Radix Glycyrrhizae, 20-35 parts of radix platycodis, 10-20 parts of Radish seeds.
2. a preparation technology for respiratory diseases in pigs health care Chinese medicine powder, is characterized in that: it comprises the following steps:
(1) 20-35 parts of Bulbus Fritillariae Cirrhosaes, 20-35 parts of the tubers of stemona, 15-25 parts, Radix Glycyrrhizae, 20-35 parts of four kinds of Chinese medicines of radix platycodi are crushed to 180 orders with micronizer respectively above as standby material;
(2) 10-20 parts of Radish seeds are crushed to 40 orders with pulverizer above for subsequent use;
(3) take above-mentioned for subsequent use former medicine by above-mentioned part by weight respectively and be placed in mixer and mix 25-30 minutes, blanking is packaged into bag.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210542262.1A CN103055219B (en) | 2012-12-14 | 2012-12-14 | A kind of respiratory diseases in pigs health care Chinese medicine powder and preparation technology thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210542262.1A CN103055219B (en) | 2012-12-14 | 2012-12-14 | A kind of respiratory diseases in pigs health care Chinese medicine powder and preparation technology thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103055219A CN103055219A (en) | 2013-04-24 |
| CN103055219B true CN103055219B (en) | 2016-05-25 |
Family
ID=48098313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210542262.1A Active CN103055219B (en) | 2012-12-14 | 2012-12-14 | A kind of respiratory diseases in pigs health care Chinese medicine powder and preparation technology thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103055219B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108208399A (en) * | 2017-12-31 | 2018-06-29 | 定远县恒基牧业有限公司 | A kind of organic feed for improving the sow speed of growth and preparation method thereof |
| CN108125039A (en) * | 2017-12-31 | 2018-06-08 | 定远县恒基牧业有限公司 | A kind of piglet organic feed for improving the speed of growth and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1068740A (en) * | 1991-07-13 | 1993-02-10 | 贾虎子 | The compound method of pneumonia Xiaolingsan |
| CN101406686A (en) * | 2008-11-14 | 2009-04-15 | 宋冰 | Medicament for mainly curing bronchial asthma and preparation method thereof |
-
2012
- 2012-12-14 CN CN201210542262.1A patent/CN103055219B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1068740A (en) * | 1991-07-13 | 1993-02-10 | 贾虎子 | The compound method of pneumonia Xiaolingsan |
| CN101406686A (en) * | 2008-11-14 | 2009-04-15 | 宋冰 | Medicament for mainly curing bronchial asthma and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103055219A (en) | 2013-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101869224B (en) | Feed additive for improving lactation performance of lactating sows and preparation method thereof | |
| CN101584747A (en) | Antibacterial antivirus Chinese medicinal composition for animal | |
| CN102139052A (en) | Disease-prevention and healthcare Chinese medicinal preparation for breeding pig | |
| CN104543408A (en) | Chinese herbal medicine immunoregulator and application thereof in piglet breeding | |
| CN103719623A (en) | Traditional Chinese medicine feed additive capable of preventing or relieving stress syndrome of weaned pigs and preparation method of feed additive | |
| CN111789190A (en) | Traditional Chinese medicine feed additive for improving animal organism immunity, feed and preparation method | |
| CN103432254B (en) | Traditional Chinese medicinal microecologics for preventing porcine respiratory diseases and preparation method for traditional Chinese medicinal microecologics | |
| CN103055219B (en) | A kind of respiratory diseases in pigs health care Chinese medicine powder and preparation technology thereof | |
| CN103006820A (en) | Chinese medicinal composition with functions of clearing heat and drying dampness and preparation method thereof | |
| CN104208163A (en) | Chinese veterinary drug composition for improving animal immunity as well as application and preparation method of Chinese veterinary drug composition | |
| CN102258635A (en) | Antibacterial Chinese medicine for veterinary use | |
| CN109316598B (en) | Traditional Chinese medicine, antibacterial peptide and Chinese herbal medicine composite preparation for preventing and treating pig diarrhea as well as preparation method and application | |
| KR20170066622A (en) | Antiviral effects of narasin in swine feed | |
| CN101249097B (en) | Applications of ash tree flowers polysaccharide for preparing preventing and controlling pig virosis medicament | |
| CN101167977B (en) | Chinese medicinal herb additive for preventing chicken high febrile disease | |
| CN113812522A (en) | Pig feed additive formula and pig feed prepared by same | |
| CN103656366B (en) | A kind ofly treat Chinese medicine of diarrhea of weaned piglets in winter and preparation method thereof | |
| CN102755342B (en) | Compound paracetamol injection and preparation method thereof | |
| CN102247390B (en) | Medicine for treating bacterial air sacculitis in livestock and preparation method thereof | |
| CN106853015A (en) | A kind of herbal mixture powder for improving sow reproductive performance and preparation method thereof | |
| CN104758390A (en) | Botanical drug compound preparation for preventing and treating porcine diarrhea and preparation method thereof | |
| CN105770054A (en) | Pharmaceutical composition for preventing and treating chicken coccocidiosis, additive and feed | |
| CN103203004B (en) | Medicinal composition with dysentery stopping effect and preparation method thereof | |
| CN103040934A (en) | Chinese medicinal composition for treating white scour of piglet and preparation method thereof | |
| CN101584803B (en) | Medicament for improving immunizing power and preparing method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Liang Shiren Inventor after: Ai Chunxiang Inventor after: Wen Qingqi Inventor after: Zhou Shengchang Inventor after: Shi Jiancheng Inventor after: Huang Jing Inventor after: Xiao Liping Inventor after: Jiang Wen Inventor after: Ye Junbiao Inventor after: Wu Youlin Inventor before: Liang Shiren |
|
| COR | Change of bibliographic data | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20160216 Address after: 333100 Jiangxi city of Shangrao province Poyang County Ashida light industry base Applicant after: JIANGXI AOXIN BIOTECHNOLOGY Co.,Ltd. Address before: 363000 Fujian city of Zhangzhou Province in stone town, Wu Guan Lu Wang men Cun Applicant before: ZHANGZHOU AONONG ANIMAL HUSBANDRY TECHNOLOGY Co.,Ltd. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20210323 Address after: 333100 Lutian light industry base, Poyang County, Shangrao City, Jiangxi Province Patentee after: JIANGXI AOXIN BIOTECHNOLOGY Co.,Ltd. Patentee after: FUJIAN AONONG BIOLOGICAL TECHNOLOGY GROUP Co.,Ltd. Address before: 333100 Lutian light industry base, Fanyang County, Shangrao City, Jiangxi Province Patentee before: JIANGXI AOXIN BIOTECHNOLOGY Co.,Ltd. |
|
| CP01 | Change in the name or title of a patent holder | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 333100 Lutian light industry base, Poyang County, Shangrao City, Jiangxi Province Patentee after: Jiangxi Yixinbao Biotechnology Co.,Ltd. Patentee after: FUJIAN AONONG BIOLOGICAL TECHNOLOGY GROUP Co.,Ltd. Address before: 333100 Lutian light industry base, Poyang County, Shangrao City, Jiangxi Province Patentee before: JIANGXI AOXIN BIOTECHNOLOGY Co.,Ltd. Patentee before: FUJIAN AONONG BIOLOGICAL TECHNOLOGY GROUP Co.,Ltd. |